Halozyme Therapeutics | HALO

Aktienkurs
124.76
Täglich Wechseln
0.22 0.18%
Monatlich
10.96%
Jährlich
86.53%
Q4 Prognose
119.27

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-11-05 FY2026Q3 PM 2.18 1.72
2026-08-06 FY2026Q2 PM 2.28 1.81 1.54
2026-05-11 FY2026Q1 PM 1.60 1.76 1.11
2026-02-17 FY2025Q4 PM -0.24 1.9 1.26
2025-11-03 FY2025Q3 PM 1.72 1.59 1.27



Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 19.96 -0.35 -1.72% -8.15% 2026-10-23
Agios Pharmaceuticals 36.49 -0.70 -1.88% -13.30% 2026-10-23
Alnylam Pharmaceuticals 228.27 0.99 0.44% -50.74% 2026-10-23
Amgen 442.04 -5.24 -1.17% 51.51% 2026-10-23
Amarin 11.82 0.22 1.90% -39.26% 2026-10-23
Baxter International 25.45 -0.20 -0.78% 10.56% 2026-10-23
Cara Therapeutics 0.97 -0.05 -4.69% -81.16% 2026-10-22
Cytokinetics 61.34 -1.00 -1.60% 6.67% 2026-10-23
DBV Technologies 9.65 -0.03 -0.31% -35.06% 2026-10-23
Halozyme Therapeutics 124.76 0.22 0.18% 86.53% 2026-10-23

Preis Tag Jahr Datum
USND 26061 51.74 0.20% 12.31% 2026-10-23
US Index 2000 2777 -6.58 -0.24% 10.47% 2026-10-23